Abstract

A lateral flow (LF) device combined with Quantum dots (QDs) technology was developed for rapiddetection of a specific mycobacterial flavoprotein reductase (FprA). In order to develop the LF assay based on a double-antibody sandwich format, two monoclonal antibodies recognizing different epitopes located in separated FprA domains, were identified. The first monoclonal antibody was immobilized onto the detection zone of a porous nitrocellulose membrane, whereas an other monoclonal antibody was conjugated to QDs nanoparticles as a detection system. Using these monoclonal antibodies we recorded a good fluorescence signal, whose intensity was directly proportional to the concentration of FprA protein. The use of antibodies conjugated with fluorescent semiconductor QDs via biotin-streptavidin bridge, allowed the detection of FprA protein at concentration as low as 12.5 pg/?l in less than 10 min. The reported technology could be useful for the diagnostic investigation of Mycobacterium tuberculosis and other human pathogens in clinical specimens.

Autore Pugliese

• Santino Angelo , Poltronieri Palmiro

Tutti gli autori

• Cimaglia F.; Aliverti A.; Chiesa M.; Poltronieri P.; De Lorenzis E.; Santino A.; Sechi L.A.

Titolo volume/Rivista

Nanotechnology development

Anno di pubblicazione

2012

ISSN

2038-968X

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile